Nikin Patel
Corporate Officer/Principal bei Royal Pharmaceutical Society of Great Britain
Profil
Nikin Patel is the founder of Catalent Nottingham Ltd.
(founded in 1998) and Locate Bio Ltd.
(founded in 2001).
At Catalent Nottingham Ltd., he held the title of Chief Executive Officer & Director.
At Locate Bio Ltd., he held the title of Director from 2001 to 2014.
Currently, Dr. Patel is a Member at the Royal Pharmaceutical Society of Great Britain.
He previously worked at Catalent JNP, Inc. as the Chief Operating Officer from 2018 to 2018.
Dr. Patel earned a doctorate degree from The University of Nottingham.
Aktive Positionen von Nikin Patel
| Unternehmen | Position | Beginn |
|---|---|---|
Royal Pharmaceutical Society of Great Britain
 Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Nikin Patel
| Unternehmen | Position | Ende |
|---|---|---|
| JUNIPER PHARMACEUTICALS INC | Geschäftsführer | 14.08.2018 |
Locate Bio Ltd.
 Locate Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Locate Bio Ltd. operates as a regenerative medicine development company. The firm focuses on clinical problems in which regeneration of human tissue will displace biomaterial or drug therapies. Its products are orthopaedic matrices with unique properties for hard to heal clinical applications. The company was founded by Robin Quirk and is headquartered in Nottingham, the United Kingdom. | Gründer | 01.01.2014 |
Catalent Nottingham Ltd.
 Catalent Nottingham Ltd. BiotechnologyHealth Technology Part of Catalent, Inc., Catalent Nottingham Ltd. is a company that provides pharmaceutical development, clinical trial manufacturing, and contract research services. Catalent Nottingham Ltd. is based in Nottingham, UK. Catalent Nottingham was acquired by Catalent JNP, Inc., part of Catalent, Inc. from August 15, 2018 on September 12, 2013 for $25.40 million. The British company was founded in 1997 by Nikin Patel. | Gründer | - |
Ausbildung von Nikin Patel
| The University of Nottingham | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Catalent JNP, Inc.
 Catalent JNP, Inc. Pharmaceuticals: MajorHealth Technology Catalent JNP, Inc. engages in the research and development of drugs and therapeutics. It offers analytical characterization and pre-formulation testing; formulation development; and clinical manufacturing of capsules and tablets. The company was founded in December 1986 and is headquartered in Somerset, NJ. | Health Technology |
Royal Pharmaceutical Society of Great Britain
Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Commercial Services |
Catalent Nottingham Ltd.
Catalent Nottingham Ltd. BiotechnologyHealth Technology Part of Catalent, Inc., Catalent Nottingham Ltd. is a company that provides pharmaceutical development, clinical trial manufacturing, and contract research services. Catalent Nottingham Ltd. is based in Nottingham, UK. Catalent Nottingham was acquired by Catalent JNP, Inc., part of Catalent, Inc. from August 15, 2018 on September 12, 2013 for $25.40 million. The British company was founded in 1997 by Nikin Patel. | Health Technology |
Locate Bio Ltd.
Locate Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Locate Bio Ltd. operates as a regenerative medicine development company. The firm focuses on clinical problems in which regeneration of human tissue will displace biomaterial or drug therapies. Its products are orthopaedic matrices with unique properties for hard to heal clinical applications. The company was founded by Robin Quirk and is headquartered in Nottingham, the United Kingdom. | Commercial Services |
